Latin America is hardly the latest new region to be discovered for conducting pharmaceutical clinical trials.
After the Phase 1 trial, a Phase 2 clinical trial will follow in the United States at the end of this year or early next year.
Previous clinical trials demonstrated ASC40 is safe and inhibits human facial sebum production in a dose-dependent fashion
The trial will analyze the safety and tolerability of the shot in healthy adult participants aged 18 to 30 years.
On carrying out an analysis, the DSMB found the treatment of NOX-A12 plus radiotherapy and bevacizumab to be safe.
A design for the phase 3 ZILO-301 clinical trial, assessing the efficacy of zilovertamab plus ibrutinib for patients with mantle cell lymphoma, has been selected.
A second, two-part Phase 2a/2b study will assess the safety and efficacy of VBI-2601 (BRII-179) as an add-on therapy to standard-of-care treatment in chronic hepatitis B patients.
On November 24, 2021, Kintor Pharma announced that the China's National Medical Products Administration (NMPA) greenlighted the protocol for the pivotal phase III study of KX-826.
The agent will be administered to patients with relapsed small cell lung cancer.
Saniona today announced the initiation of a Phase 2b clinical trial of Tesomet in patients with hypothalamic obesity.